You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Insights

Cell Therapy: Process Design Considerations To Support Commercialization

Mar 28, 2017

Insights

Cell Therapy: Process Design Considerations To Support Commercialization

Mar 28, 2017

Cell therapies have the potential to revolutionize the biopharmaceutical world, but today’s processes, logistics, and delivery make for a challenging entry into the sector’s growth curve. As the industry evolves, we will have to answer (at least) three important questions when bringing these exciting new therapies to market:

 

What benefit does the therapy provide in terms of patient longevity and product efficacy?

What will the cost of the new therapy be, especially in the early stages of low volumes, and how can process manufacturing impact that cost?

How can we, as an industry, provide the therapy that requires, in some cases, the patient to be resident/connected for cell collection and re-infusion, given that the scale of operation may force the providers to have only one national manufacturing site for the therapy?

To read more go to https://www.bioprocessonline.com/doc/cell-therapy-process-design-considerations-to-support-commercialization-0001

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue